These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 19891946)
1. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Low-density lipoprotein cholesterol and coronary heart disease: the importance of reaching target goals with statin therapy. Lewis SJ J Fam Pract; 2009 Nov; 58(11 Suppl Urgent):S32-40. PubMed ID: 19891946 [TBL] [Abstract][Full Text] [Related]
2. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Assessing cardiovascular risk one patient at a time. Davidson MH J Fam Pract; 2009 Nov; 58(11 Suppl Urgent):S26-31. PubMed ID: 19891945 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508 [TBL] [Abstract][Full Text] [Related]
4. Cholesterol and coronary events. The current thinking. Jones PH Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of statin therapy in adults with coronary heart disease. Wilt TJ; Bloomfield HE; MacDonald R; Nelson D; Rutks I; Ho M; Larsen G; McCall A; Pineros S; Sales A Arch Intern Med; 2004 Jul; 164(13):1427-36. PubMed ID: 15249352 [TBL] [Abstract][Full Text] [Related]
7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046 [TBL] [Abstract][Full Text] [Related]
8. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
9. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE; Feely J; Sigurdsson EL; Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694 [TBL] [Abstract][Full Text] [Related]
10. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
11. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Bersot TP; Pépin GM; Mahley RW Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998 [TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
13. Statins and LDL-cholesterol lowering: an overview. Stroes E Curr Med Res Opin; 2005; 21 Suppl 6():S9-16. PubMed ID: 16138936 [TBL] [Abstract][Full Text] [Related]
14. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C. Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C; Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528 [TBL] [Abstract][Full Text] [Related]
15. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study. Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A; Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888 [TBL] [Abstract][Full Text] [Related]
16. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A; Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of atorvastatin after LDL-cholesterol-based dose selection in high risk dyslipidaemic patients: results of the target dose study. Ducobu J; Claeys M; Commers K; Van Mieghem W; Nachtergaele H; Vandenbroucke M; Deforce J Curr Med Res Opin; 2007 Aug; 23(8):1821-7. PubMed ID: 17609019 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. Koren MJ; Hunninghake DB; J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006 [TBL] [Abstract][Full Text] [Related]
20. Rising to the challenge of treating high-risk patients. Guthrie RM Am J Manag Care; 2006 Oct; 12(11 Suppl):S318-24. PubMed ID: 17042674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]